title: Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report.
abstract: BACKGROUND
  Posterior reversible encephalopathy syndrome (PRES) is an uncommon pathology characterized by the acute onset of headache, vomiting, altered consciousness, seizures and focal neurological deficits. It was initially described in the setting of hypertension, uremia and immunosuppression. In the last decade there have been emerging reports of PRES in patients with advanced human immunodeficiency virus (HIV)-infection in the presence of hypertension, dialysis, hypercalcaemia and two opportunistic infections: blastomycosis and tuberculosis (TB).
  
  
  METHODS
  Here we present the case of a 54 year old male being treated for disseminated varicella zoster virus (VZV) and vasculopathy in the setting of HIV infection who acutely deteriorated to the point of requiring intubation. His clinicoradiological diagnosis was of PRES and he subsequently improved within 72 h with supportive management. Serial neuroimaging correlated with the clinical findings. The pathogenesis of PRES is poorly understood but is thought to stem from vasogenic oedema either as a result of loss of endothelial integrity and transudate of fluid across the blood-brain barrier, or secondary to vasospasm resulting in tissue oedema in the absence of infarction. How HIV infection impacts on this model is unclear. It is possible the HIV infection causes endothelial dysfunction and disruption of the blood-brain barrier that may be further exacerbated by infections in the central nervous system.
  
  
  CONCLUSIONS
  The phenomenon of PRES in advanced HIV is an important clinical entity for both physicians and critical care doctors to recognize firstly given its potential mortality but also because of its favourable prognosis and reversibility with supportive care and treatment of underlying causes.
authors: HIV, Immunology and Infectious Diseases Unit, St Vincent's Hospital, 390 Victoria Street Darlinghurst, 2010, Sydney, NSW, Australia. ssasson@stvincents.com.au.
authors: Sarah C
authors: SC
authors: Sasson
authors: Aileen
authors: A
authors: Oon
authors: Joga
authors: J
authors: Chagantri
authors: Bruce J
authors: BJ
authors: Brew
authors: Andrew
authors: A
authors: Carr
mesh_terms: D060085:Coinfection; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1 / Q000502:physiology; D014645:Herpesvirus 3, Human / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D054038:Posterior Leukoencephalopathy Syndrome / Q000209:etiology / Q000821:virology*
references: Scand J Infect Dis. 2005;37(6-7):524-6
references: 16012020
references: Am J Hypertens. 2002 May;15(5):465-7
references: 12022250
references: Case Rep Med. 2012;2012:914035
references: 23093975
references: Lancet Neurol. 2009 Aug;8(8):731-40
references: 19608099
references: J Am Coll Cardiol. 2008 Aug 12;52(7):569-76
references: 18687253
references: Neurology. 2008 Mar 11;70(11):853-60
references: 18332343
references: Case Rep Ophthalmol Med. 2012;2012:850176
references: 23243537
references: Circulation. 2001 Jul 17;104(3):257-62
references: 11457741
references: N Engl J Med. 1996 Feb 22;334(8):494-500
references: 8559202
references: BMJ Case Rep. 2012 Jun 25;2012:
references: 22736775
references: AIDS. 2007 Mar 30;21(6):781-2
references: 17413707
references: Case Rep Neurol Med. 2013;2013:473618
references: 23738165
references: J Neuropathol Exp Neurol. 1990 Jul;49(4):357-70
references: 2362185
references: Clin Infect Dis. 2008 Jan 15;46(2):e19-22
references: 18171242